Inventor
KINGSMAN SUSAN MARY
GB23 patents
⚠️ This page may combine multiple inventors who share the name “KINGSMAN SUSAN MARY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
OXFORD BIOMEDICA LTD
18 patentsUS6312682B1Nov 6, 2001
Retroviral vectors
OXFORD BIOMEDICA LTD115 citations98
US7303910B2Dec 4, 2007
Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
OXFORD BIOMEDICA LTD137 citations97
US7056699B2Jun 6, 2006
Lentiviral LTR-deleted vector
OXFORD BIOMEDICA LTD46 citations96
US6924123B2Aug 2, 2005
Lentiviral LTR-deleted vector
OXFORD BIOMEDICA LTD64 citations96
US6852703B1Feb 8, 2005
Tumor targeted vector
OXFORD BIOMEDICA LTD39 citations94
US6096538AAug 1, 2000
Retroviral vectors
OXFORD BIOMEDICA LTD52 citations94
US7419829B2Sep 2, 2008
Vector system
OXFORD BIOMEDICA LTD60 citations93
US7198784B2Apr 3, 2007
Retroviral vectors
OXFORD BIOMEDICA LTD43 citations92
US6669936B2Dec 30, 2003
Retroviral vectors
OXFORD BIOMEDICA LTD34 citations92
US6235522B1May 22, 2001
Lentiviral vectors
OXFORD BIOMEDICA LTD40 citations92
US7074909B2Jul 11, 2006
Antibodies
OXFORD BIOMEDICA LTD27 citations89
US6168916B1Jan 2, 2001
Host adaptation of retroviral vectors
OXFORD BIOMEDICA LTD23 citations88
US7531648B2May 12, 2009
Vector encoding an antibody that binds 5T4 antigen
OXFORD BIOMEDICA LTD8 citations82
US7514546B2Apr 7, 2009
Antibodies
OXFORD BIOMEDICA LTD13 citations82
US6808922B1Oct 26, 2004
Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
OXFORD BIOMEDICA LTD14 citations82
US6800281B2Oct 5, 2004
Lentiviral-mediated growth factor gene therapy for neurodegenerative diseases
OXFORD BIOMEDICA LTD17 citations79
US7888115B2Feb 15, 2011
MHC class I peptide epitopes from the human 5T4 tumor-associated antigen
OXFORD BIOMEDICA LTD1 citations60
US7635687B2Dec 22, 2009
Vector system
OXFORD BIOMEDICA LTD2 citations59